Medicare s COVID-19 testing costs reached over $2 billion in 2022. Experts say financial incentives and a lack of regulation early in the pandemic led to fraud and overspending.
Medicare’s COVID-19 testing costs reached over $2 billion in 2022. The growing costs concern some experts, who say financial incentives and a lack of regulation early in the pandemic led to fraud and overspending.
Overspending and fraud helped grow Medicare’s COVID-19 testing to over $2 billion in 2022, thanks in part to government incentives some experts say are no longer needed.
When pop-up COVID-19 testing sites opened all over Chicago and cities across the U.S. late last year, many had the same question on their minds: Where did they.